Altogether, we provide novel insight into the function of OSBPL2/ORP2 in the developmental progression of preadipocytes and suggest OSBPL2/ORP2 may be a potential therapeutic target for the treatment of obesity-related diseases. The gene discussed is OSBPL2; the disease is obesity due to melanocortin 4 receptor deficiency.